COVID-19 and diabetes: Can DPP4 inhibition play a role?

被引:216
作者
Iacobellis, Gianluca [1 ]
机构
[1] Univ Miami, Dept Med, Div Endocrinol Diabet & Metab, Coral Gables, FL 33124 USA
关键词
D O I
10.1016/j.diabres.2020.108125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 10 条
  • [1] Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
    Conarello, SL
    Li, ZH
    Ronan, J
    Roy, RS
    Zhu, L
    Jiang, GQ
    Liu, F
    Woods, J
    Zycband, E
    Moller, DE
    Thornberry, NA
    Zhang, BB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) : 6825 - 6830
  • [2] Fan C, 2018, VIRUSES, P10
  • [4] Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection
    Kulcsar, Kirsten A.
    Coleman, Christopher M.
    Beck, Sarah E.
    Frieman, Matthew B.
    [J]. JCI INSIGHT, 2019, 4 (20)
  • [5] Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice
    Li, Kun
    Wohlford-Lenane, Christine L.
    Channappanavar, Rudragouda
    Park, Jung-Eun
    Earnest, James T.
    Bair, Thomas B.
    Bates, Amber M.
    Brogden, Kim A.
    Flaherty, Heather A.
    Gallagher, Tom
    Meyerholz, David K.
    Perlman, Stanley
    McCray, Paul B., Jr.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (15) : E3119 - E3128
  • [6] Middle East respiratory syndrome
    Memish, Ziad A.
    Perlman, Stanley
    Van Kerkhove, Maria D.
    Zumla, Alimuddin
    [J]. LANCET, 2020, 395 (10229) : 1063 - 1077
  • [7] Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
    Raj, V. Stalin
    Mou, Huihui
    Smits, Saskia L.
    Dekkers, Dick H. W.
    Mueller, Marcel A.
    Dijkman, Ronald
    Muth, Doreen
    Demmers, Jeroen A. A.
    Zaki, Ali
    Fouchier, Ron A. M.
    Thiel, Volker
    Drosten, Christian
    Rottier, Peter J. M.
    Osterhaus, Albert D. M. E.
    Bosch, Berend Jan
    Haagmans, Bart L.
    [J]. NATURE, 2013, 495 (7440) : 251 - 254
  • [8] COVID-19 and Italy: what next?
    Remuzzi, Andrea
    Remuzzi, Giuseppe
    [J]. LANCET, 2020, 395 (10231) : 1225 - 1228
  • [9] DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trials
    Yang, Wenjia
    Cai, Xiaoling
    Han, Xueyao
    Ji, Linong
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (04) : 391 - 404
  • [10] Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
    Zhou, Fei
    Yu, Ting
    Du, Ronghui
    Fan, Guohui
    Liu, Ying
    Liu, Zhibo
    Xiang, Jie
    Wang, Yeming
    Song, Bin
    Gu, Xiaoying
    Guan, Lulu
    Wei, Yuan
    Li, Hui
    Wu, Xudong
    Xu, Jiuyang
    Tu, Shengjin
    Zhang, Yi
    Chen, Hua
    Cao, Bin
    [J]. LANCET, 2020, 395 (10229) : 1054 - 1062